Sign in
4

Changes in Ownership

Nuvectis Pharma, Inc. Filed Acc 0001104659-22-013142

Chairman & CEO bought 232,500 shares at an average $4.96 ($1,153,145)

From the SEC's structured data for this filing

Trades in this filing

BENTSUR RON · Chairman & CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2022-02-04 Purchase : show line 1 in the form +200,000 $5.00 $1,000,000 2,765,459 D
2022-02-04 Purchase : show line 2 in the form +12,500 $3.89 $48,625 2,777,959 D
2022-02-07 Purchase : show line 3 in the form +14,000 $3.93 $55,020 2,791,959 D
2022-02-07 Purchase : show line 4 in the form +6,000 $8.25 $49,500 2,797,959 D
Open-market purchases · 232,500 sh · avg $4.96 · $1,153,145
Loading xslF345X03/tm225864-1_4.xml…